Home/Filings/4/0001209191-17-026541
4//SEC Filing

Epizyme, Inc. 4

Accession 0001209191-17-026541

CIK 0001571498operating

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 1:34 PM ET

Size

11.3 KB

Accession

0001209191-17-026541

Insider Transaction Report

Form 4
Period: 2017-04-10
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2017-04-1077717,102 total
    Exercise: $0.00Common Stock (777 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2017-04-10+77738,634 total
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2017-04-10+1,68237,857 total
  • Exercise/Conversion

    Restricted Stock Units

    2017-04-101,68237,002 total
    Exercise: $0.00Common Stock (1,682 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of Epizyme, Inc. common stock upon vesting.
  • [F2]This award, granted on February 9, 2016, pursuant to the Company's 2013 Stock Incentive plan, vests as to 25% of the total award on February 9, 2016, a year from the commencement of employment, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.
  • [F3]This award, granted on February 9, 2015, pursuant to the Company's 2013 Stock Inventive Plan, vests as to 25% of the total award on February 9, 2016, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001571498

Filing Metadata

Form type
4
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 1:34 PM ET
Size
11.3 KB